GlaxoSmithKline and Pfizer have settled a lawsuit over patent rights for their RSV vaccines, Arexvy and Abrysvo. The case has been dismissed with prejudice, preventing it from being refiled. Both companies have not provided further details on the settlement.
Read MoreDid you find this insightful?
Amazing
Bad
Just Okay